158 related articles for article (PubMed ID: 16724522)
1. [History of treatment of Parkinson disease].
Götz W
Pharm Unserer Zeit; 2006; 35(3):190-7. PubMed ID: 16724522
[No Abstract] [Full Text] [Related]
2. [Receptor-mediated Parkinson drugs].
Böckler F
Pharm Unserer Zeit; 2006; 35(3):204-16. PubMed ID: 16724524
[No Abstract] [Full Text] [Related]
3. [Drug therapy in Parkinson's disease].
van Hilten JJ; Roos RA
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
[TBL] [Abstract][Full Text] [Related]
4. Levodopa: 50 years of a revolutionary drug for Parkinson disease.
Fahn S; Poewe W
Mov Disord; 2015 Jan; 30(1):1-3. PubMed ID: 25488146
[No Abstract] [Full Text] [Related]
5. The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961.
Birkmayer W; Hornykiewicz O
Wien Klin Wochenschr; 2001 Nov; 113(22):851-4. PubMed ID: 11763859
[No Abstract] [Full Text] [Related]
6. L-DOPA.
Hornykiewicz O
J Parkinsons Dis; 2017; 7(s1):S3-S10. PubMed ID: 28282813
[No Abstract] [Full Text] [Related]
7. Parkinson's disease. A half century of progress.
Jankovic J
Neurology; 2001 Nov; 57(10 Suppl 3):S1-3. PubMed ID: 11771154
[No Abstract] [Full Text] [Related]
8. [L-dopa: a fascinating history].
García de Yébenes J; García Ruiz P
Neurologia; 1998; 13 Suppl 1():36-40. PubMed ID: 9859684
[No Abstract] [Full Text] [Related]
9. How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago.
Hornykiewicz O
Wien Klin Wochenschr; 2001 Nov; 113(22):855-62. PubMed ID: 11762121
[No Abstract] [Full Text] [Related]
10. [History of discoveries and advances in the studies of parkinsonism].
Kuran W
Neurol Neurochir Pol; 1992; 26(4):529-37. PubMed ID: 1484580
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l-Dopa.
Kim HJ; Jeon BS; Jenner P
Int Rev Neurobiol; 2017; 132():295-343. PubMed ID: 28554412
[TBL] [Abstract][Full Text] [Related]
12. Current pharmacotherapeutic treatment options in Parkinson's disease.
Rezak M
Dis Mon; 2007 Apr; 53(4):214-22. PubMed ID: 17586328
[TBL] [Abstract][Full Text] [Related]
13. The discovery of dopamine deficiency in the parkinsonian brain.
Hornykiewicz O
J Neural Transm Suppl; 2006; (70):9-15. PubMed ID: 17017502
[TBL] [Abstract][Full Text] [Related]
14. [Short history of L-Dopa].
García Ruiz PJ; Meseguer E
Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
[TBL] [Abstract][Full Text] [Related]
15. Harbinger of storm: influence of Oliver Sacks on levodopa therapy in early 1970s.
Santos-Lobato BL; Tumas V
Arq Neuropsiquiatr; 2016 Aug; 74(8):687-9. PubMed ID: 27556381
[TBL] [Abstract][Full Text] [Related]
16. History of levodopa and dopamine agonists in Parkinson's disease treatment.
Tolosa E; Martí MJ; Valldeoriola F; Molinuevo JL
Neurology; 1998 Jun; 50(6 Suppl 6):S2-10; discussion S44-8. PubMed ID: 9633679
[TBL] [Abstract][Full Text] [Related]
17. [Medicinal treatment of idiopathic Parkinson's disease].
Klockgether T
Nervenarzt; 2003 Mar; 74 Suppl 1():S12-21. PubMed ID: 12624679
[TBL] [Abstract][Full Text] [Related]
18. Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. 2000.
Fraix V; Pollak P; Van Blercom N; Xie J; Krack P; Koudsie A; Benabid AL
Neurology; 2001 Nov; 57(10 Suppl 3):S60-2. PubMed ID: 11775603
[No Abstract] [Full Text] [Related]
19. The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
Fahn S
Mov Disord; 2015 Jan; 30(1):4-18. PubMed ID: 25491387
[TBL] [Abstract][Full Text] [Related]
20. The first miracle in neurodegenerative disease: the discovery of oral levodopa.
Kordower JH; Goetz CG
Brain Res Bull; 1999; 50(5-6):377-8. PubMed ID: 10643443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
